Nurix Therapeutics (NRIX) Stock News
$NRIX · NASDAQ · HEALTHCARE · 5 stories in 30 daysBORSA has published 5 stories on Nurix Therapeutics (NRIX) in the past 30 days. BORSA’s news read on NRIX is leaning bullish at 56/100, unchanged over 24 hours, based on 4 company events over the past 7 days. Nurix Therapeutics last reported quarterly results on Jul 9, 2026, for the quarter ended May 31, 2026.
The wire on $NRIX
newest first · updated · direct subject stories onlyRBC Capital cuts Nurix Therapeutics price target to $35.00
RBC Capital lowered its price target for Nurix Therapeutics from $36.00 to $35.00.
bearish 40 · impact 20Oppenheimer lifts Nurix Therapeutics price target to $32.00
Oppenheimer increased its price target for Nurix Therapeutics from $28.00 to $32.00 per share.
bullish 65 · impact 30
